510
Clin. Cardiol. Vol. 25, November 2002
References
14. Ikonomidis I, Andreotti F, Economou E, Stefanadis C, Toutouzas P,
Nihoyannopoulos P: Increased proinflammatory cytokines in pa-
tients with chronic stable angina and their reduction by aspirin.
Circulation 1999;100:793–798
1.
Califf RM: State of the art: ACS treatment at the turn of the century.
Eur Heart J 2000;2(suppl F):F2–F6
1
5. Tashiro H, Shimokawa H, Yamamoto K, Nagano M, Monohara M,
Muramatsu K, Takeshita A: Monocyte-related cytokines in acute
myocardial infarction. Am Heart J 1995;130:446–452
2.
Topol E: Patient stratification and its predictive value for cardiac
events. Eur Heart J 1998;19(suppl K):K5–K7
3.
Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG,
Pepys MB, Maseri A: The prognostic value of C-reactive protein
and serum amyloid A protein in severe unstable angina. N Engl J
Med 1994;331:417–424
16. Ross R: Atherosclerosis—an inflammatory disease. N Engl J Med
1999;340:115–126
1
7. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT:
Macrophage infiltration in acute coronary syndromes. Implications
for plaque rupture. Circulation 1994;90:775–778
4.
Becker RC, Cannon CP, Bovill EG, Tracy RP, Thompson B,
Knatterud GL, Randall A, Braunwald E, for the TIMI III Inves-
tigators: Prognostic value of plasma fibrinogen concentration in pa-
tients with unstable angina and non-Q-wave myocardial infarction
18. Thorpe R, Wadhwa M, Bird CR, Mire-Sluis AR: Detection and
measurement of cytokine. Blood Rev 1992;6:133–148
19. Roth P, Stanley ER: The biology of CSF-1 and its receptor. Curr
Top Microbiol Immunol 1992;181:141–167
(TIMI IIIB Trial). Am J Cardiol 1997;79(10):1439–1440
5.
Toss H, Lindahl B, Siegbahn A, Wallentin L, for the FRISC Study
Group: Prognostic influence of increased fibrinogen and C-reactive
protein levels in unstable coronary artery disease. Circulation 1997;
20. Lendon CL, Davies MJ, Born GV, Richardson PD: Atherosclerotic
plaque caps are locally weakened when macrophage density is in-
creased. Atherosclerosis 1991;87:87–90
96:4204–4210
21. Rajavashisth TB, Andalibi A, Territo MC, Berliner JA, Navab M,
Fogelman AM, Lusis AJ: Induction of endothelial cell expression
of granulocyte and macrophage colony-stimulating factors by
modified low-density lipoproteins. Nature 1990;344:254–257
22. Davies MJ: A macro and micro view of coronary vascular insult in
ischaemic heart disease. Circulation 1990;82(suppl II):II-38–II-46
23. Lam JY, Chesebro JH, Steele PM, Badimon L, Fuster V: Is va-
sospasm related to platelet deposition? Relationship in a porcine
preparation of arterial injury in vivo. Circulation 1987;75:243–248
6
.
Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Mon-
aco C, Rebuzzi AG, Ciliberto G, Maseri A: Elevated levels of inter-
leukin-6 in unstable angina. Circulation 1996;94:847–877
Tashiro H, Shimokawa H, Yamamoto K, Monohara M, Tada H,
Takeshita A: Altered plasma levels of cytokines in patients with is-
chemic heart disease. Coron Art Dis 1997;8:143–147
7.
8.
Biasucci LM, Liuzzo G, Fantuzzi G, Ciligiuri G, Rebuzzi AG,
Ginnetti F, Dinarello CA, Maseri A: Increasing levels of interleukin
2
2
2
2
4. Bhagat K, Vallance P: Inflammatory cytokines impair endothelial
(IL) -1Ra and IL-6 during the first 2 days of hospitalization in un-
dependent dilatation in human veins in vivo. Circulation 1997;96:
stable angina are associated with increased risk of in-hospital coro-
nary events. Circulation 1999;99:2079–2084
3042–3047
5. Shah PK: Circulating markers of inflammation for vascular risk
9.
Saitoh T, Kishida H, Tsukada Y, Fukuma Y, Sano J, Yasutake M,
Fukuma N, Kusama Y, Hayakawa H: Clinical significance of in-
creased plasma concentration of macrophage colony-stimulating
factor in patients with angina pectoris. J Am Coll Cardiol 2000;35:
prediction. Are they ready for prima time? Circulation 2000;105:
1758–1759
6. Ridker PM: Evaluating novel cardiovascular risk factors: Can we
do better to predict heart attacks? Ann Intern Med 1999;130:
655–665
933–937
10. Maynard SJ, Menown IBA, Adgey AAJ: Troponin T or troponin I
7. Lagrand WK, Visser CA, Hermes WT, Niessen HWM, Verheugt
FWA, Wolbink G-J, Hack E: C-reactive protein as a cardiovascular
risk factor; more than an epiphenomenon? Circulation 1999;100:
as cardiac markers in ischaemic heart disease. Heart 2000;83:
371–373
1
1. Morrow DA, Antman EM, Tansijevic M, Rifai N, de Lemos JA,
McCabe CH, Cannon CP, Braunwald E: Cardiac troponin I for
stratification of early outcomes and the efficacy of enoxaparin in
unstable angina: A TIMI-11B substudy. J Am Coll Cardiol 2000;
96–102
2
8. Fatah K, Hamsten A, Blomback M: Fibrin gel network characteris-
tics and coronary heart disease: Relations to plasma fibrinogen con-
centration, acute phase protein, serum lipoproteins and coronary
atherosclerosis. Thromb Haemost 1992;68:130–135
9. Kannel WB, Wolf PA, Castelli WP, D’Agostino RB: Fibrinogen
and risk of cardiovascular disease: The Framingham Study. J Am
Med Assoc 1987;258:1183–1186
36:1812–1817
1
2. Rizic DG, Healy S, Margulis A, Vandam D, Bakalyar D, Timmis
G, Grines C, O’Neill WW, Schreiber TL: A new clinical classifica-
tion for hospital prognosis of unstable angina pectoris. Am J
Cardiol 1995;75:993–997
2
3
0. Herity NA: Interleukin 6: A message from the heart. Heart 2000;
84:9–10
1
3. Savonitto S, Ardissino D, Granger CB, Morando G, Prando MD,
Mafrici A, Cavallini C, Melandri G, Thompson TD, Vaharian A,
Ohman EM, Califf RM, Van de Worf F, Topol EJ: Prognostic value
of the admission electrocardiogram in acute coronary syndromes.
J Am Med Assoc 1999;281:707–713
31. Le J, Vilcek J: Interleukin 6: A multifactorial cytokine regulating
immune reactions and the acute phase protein sequence. Lab Invest
1989;61:588–602
32. Lotz M: Interleukin-6. Cancer Invest 1993;11:732–742